Listar por tema "T cell leukemia"

Ordenar por:Orden:Resultados:

  • Barros, N.; Woll, F.; Watanabe, L.; Montes Delgado, Martin (BMJ Publishing Group, 2012)
    Research of human T lymphotropic virus type I (HTLV-1)-associated diseases is mostly focused on inflammatory and lymphoproliferative disorders. However, the immunosuppressive consequences of HTLV-1 infection are frequently ...
  • Moens, B.; Decanine, D.; Menezes, S.M.; Khouri, R.; Silva-Santos, G.; Lopez, G.; Alvarez, C.; Talledo Albujar, Michael John; Gotuzzo Herencia, José Eduardo; de Almeida Kruschewsky, R.; Galvão-Castro, B.; Vandamme, A.-M.; van Weyenbergh, J. (Public Library of Science, 2012)
    Background: Clear therapeutic guidelines for HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) are missing due to the lack of randomized double-blind controlled clinical trials. Moderate yet similar ...
  • Willems, Luc; Hasegawa, Hideki; Accolla, Roberto; Bangham, Charles; Bazarbachi, Ali; Bertazzoni, Umberto; Carneiro-Proietti, Anna Barbara de Freitas; Cheng, Hua; Chieco-Bianchi, Luigi; Ciminale, Vincenzo; Coelho-dos-Reis, Jordana; Esparza, José; Gallo, Robert C.; Gessain, Antoine; Gotuzzo Herencia, José Eduardo; Hall, William; Harford, Joseph; Hermine, Olivier; Jacobson, Steven; Macchi, Beatrice; Macpherson, Calum; Mahieux, Renaud; Matsuoka, Masao; Murphy, Edward; Peloponese, Jean-Marie; Simon, Viviana; Tagaya, Yutaka; Taylor, Graham P.; Watanabe, Toshiki; Yamano, Yoshihisa (Elsevier, 2017)
    Even though an estimated 10–20 million people worldwide are infected with the oncogenic retrovirus, human T-lymphotropic virus type 1 (HTLV-1), its epidemiology is poorly understood, and little effort has been made to ...

Buscar en el Repositorio

Listar

Panel de Control